METTL3 and non-small cell lung carcinoma: Recently, Jin et al. found that METTL3 plays an oncogenic role in NSCLC by enhancing YAP translation and promoting YAP activity via miR-19143p to stimulate drug resistance and metastasis in NSCLC cells (A549 and H1299) [48].